(19)
(11) EP 1 677 790 A1

(12)

(43) Date of publication:
12.07.2006 Bulletin 2006/28

(21) Application number: 04795655.2

(22) Date of filing: 20.10.2004
(51) International Patent Classification (IPC): 
A61K 31/44(1985.01)
C07D 213/32(1985.01)
A61P 1/04(2000.01)
 C07D 213/30(1985.01)
C07D 213/38(1985.01)
(86) International application number:
PCT/US2004/034519
(87) International publication number:
WO 2005/044267 (19.05.2005 Gazette 2005/20)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 31.10.2003 US 560714 P
31.10.2003 US 560713 P

(71) Applicants:
  • AstraZeneca AB
    151 Södertälje (SE)
  • NPS PHARMACEUTICALS, INC.
    Salt Lake City Utah 84108 (US)

(72) Inventors:
  • BACH, Peter
    S-SE-431 Molndal (SE)
  • BAUER, Udo
    S-SE-431 Molndal (SE)
  • NILSSON, Karolina
    S-SE-431 Molndal (SE)
  • WALLBERG, Andreas
    S-SE-431 Molndal (SE)

(74) Representative: Plougmann & Vingtoft A/S 
Sundkrogsgade 9, P.O. Box 831
2100 Copenhagen Ø
2100 Copenhagen Ø (DK)

   


(54) ALKYNES II